Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000469547 | SCV000554538 | likely benign | PTEN hamartoma tumor syndrome | 2023-11-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000491272 | SCV000580042 | likely benign | Hereditary cancer-predisposing syndrome | 2020-05-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000491272 | SCV000686301 | likely benign | Hereditary cancer-predisposing syndrome | 2017-05-04 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000491272 | SCV002528255 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-12-17 | criteria provided, single submitter | curation | |
All of Us Research Program, |
RCV000469547 | SCV004838579 | likely benign | PTEN hamartoma tumor syndrome | 2023-05-16 | criteria provided, single submitter | clinical testing |